Screening assays identify TMPRSS2 inhibitors from drug repurposing candidates useful as COVID-19 therapeutic
![](./upload/news/image_1644511381_35170087.jpg)
Researchers used an assay toolset for discovering new transmembrane protease serine 2 inhibiting drug repurposing candidates, that can be useful as therapeutics for COVID-19 treatment.